Menu
ncarol.com
  • Home
  • Business
  • Real Estate
  • Health
  • Non-profit
  • Services
  • Beauty
  • Music
  • Education
ncarol.com

See Kai Run Partners with St. Jude Children's Research Hospital to Support Life-Saving Initiatives
ncarol.com/10222269

Trending...
  • Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
  • Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
  • AI Real Estate Company Quietly Building a National Powerhouse: reAlpha Tech Corp. (N A S D A Q: AIRE)
Redwagon Inspire St Jude Image 1 See Kai Run
BOTHELL, Wash. - ncarol.com -- See Kai Run, a leading children's footwear brand, is proud to announce its partnership with
St. Jude Children's Research Hospital® in their shared mission of Finding cures. Saving children. ® This collaboration aims to contribute to vital research and provide life-saving treatment to children battling cancer and other life-threatening diseases.

As a company dedicated to children's foot-health and well-being, See Kai Run recognizes the importance of supporting organizations that make a positive impact on families' lives. By teaming up with St. Jude, See Kai Run aims to raise donations and awareness for this critical cause.

St. Jude Children's Research Hospital is at the forefront of advancing childhood cancer treatments and defeating life-threatening diseases. Since its establishment in 1962, St. Jude has been instrumental in pushing the overall childhood cancer survival rate from 20% to over 80% today. Through this partnership, See Kai Run hopes to contribute to this remarkable progress and help save even more children's lives.

To make a difference, See Kai Run has introduced the St. Jude round-up option at checkout, enabling customers to round up their order to the next dollar and donate to the hospital's life-saving initiatives. In addition, See Kai Run will match donations of up to $1,500 through July 31, 2023, amplifying the impact of the donations.

"We are honored to partner with St. Jude Children's Research Hospital," said See Kai Run CEO, Helen Rockey. "Their commitment to finding cures and saving children aligns perfectly with our values as a company. Together, we can make a meaningful difference in the lives of children and families facing unimaginable challenges."

St. Jude Children's Research Hospital accepts children from all 50 states and around the world. Thanks to generous donors, families never receive a bill from St. Jude for treatment, travel, housing, or food so they can focus on helping their child live.

Every dollar counts in this lifesaving mission and See Kai Run encourages everyone to join their efforts. Together, we can create a better future for children battling cancer and other life-threatening diseases.

To learn more about St. Jude Children's Research Hospital and how you can support their mission, visit stjude.org.

More on ncarol.com
  • Peter J. D'Arruda Founder of Capital Financial Joins Tom Hegna on the Podcast "Financial Freedom with Tom Hegna"
  • Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
  • Run the Diamond Releases New Winter Workout Album for Baseball and Softball Athletes
  • IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
  • Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure

About See Kai Run:
See Kai Run is the premier provider of innovative, fashionable, quality-crafted footwear, proportionally engineered for children from infants to eight years old.  By combining best-in- materials, extensive R&D along with world class customer service, See Kai Run delivers the best in a children's footwear experience. See Kai Run shoe sizes run from size 3 to size 4y and are sold throughout the U.S. both online and at brick and mortar stores. See Kai Run shoes are approved by the American Podiatric Medical Association

About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats, and defeats childhood cancer and other life-threatening diseases. Its purpose is clear: Finding cures. Saving children. ® It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. When St. Jude opened in 1962, childhood cancer was considered incurable. Since then, St. Jude has helped push the overall survival rate from 20% to more than 80%, and it won't stop until no child dies from cancer. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. Because of generous donors, families never receive a bill from St. Jude for treatment, travel, housing, or food, so they can focus on helping their child live. Visit St. Jude Inspire to discover powerful St. Jude stories of hope, strength, love and kindness. Support the St. Jude mission by donating at stjude.org, liking St. Jude on Facebook, following St. Jude on Twitter, Instagram, LinkedIn and TikTok, and subscribing to its YouTube channel.

More on ncarol.com
  • EnergyStrat Launches Global LNG Risk Outlook 2025–2030
  • LTL Claims Ratio Index – Update 3Q25
  • Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
  • Billion Strong Foundation Upgrades 3X Skills + Career Finder and New AI Impact Engine
  • Holiday Decorations Most Likely to Cause Injuries

Contact
See Kai Run.
Steve Hart
***@seekairun.com


Source: See Kai Run
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • London Art Exchange Emerges as a Leading Force in UK Contemporary Art, Elevating Three Artists to Secondary-Market Success
  • myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test
  • Entering 2026 with Expanding Footprint, Strong Industry Tailwinds, and Anticipated Q3 Results: Off The Hook YS Inc. (N Y S E American: OTH)
  • Tiger-Rock Martial Arts Appoints Jami Bond as Vice President of Growth
  • Super League (N A S D A Q: SLE) Enters Breakout Phase: New Partnerships, Zero Debt & $20 Million Growth Capital Position Company for 2026 Acceleration
  • Finland's Gambling Reform Promises "Single-Click" Block for All Licensed Sites
  • Private Keys Are a Single Point of Failure: Security Advisor Gideon Cohen Warns MPC Technology Is Now the Only Defense for Institutional Custody
  • Compliance Is the Ticket to Entry: Legal Advisor Gabriela Moraes Analyzes RWA Securitization Paths Under Brazil's New Legislation
  • Coalition and CCHR Call on FDA to Review Electroshock Device and Consider a Ban
  • Spark Announces 2025 Design Award Winners
  • Whitney Hill Declares Run for Raleigh City Council District A
  • NEW Luxury Single-Family Homes Coming Soon to Manalapan - Pre-Qualify Today for Priority Appointments
  • Dominic Pace Returns to the NCIS Franchise With Guest Role on NCIS: Origins
  • Anderson Periodontal Wellness Attends 5th Joint Congress for Ceramic Implantology
  • UK Financial Ltd Completes Full Ecosystem Conversion With Three New ERC-3643 SEC-Ready Tokens As MCAT Deadline Closes Tonight
  • AI Real Estate Company Quietly Building a National Powerhouse: reAlpha Tech Corp. (N A S D A Q: AIRE)
  • Inkdnylon Expands National Uniform Embroidery Services
  • Appliance EMT Expands Appliance Repair Services to Portland, OR and Vancouver, WA
  • Next Week: The World's Best Young Pianists Arrive in Music City for the 2025 Nashville International Chopin Piano Competition
  • Revenue Optics Builds Out Its Dedicated Sales Recruiting Firm with Strategic Addition of Christine Schafer
_catLbl0 _catLbl1

Popular on ncarol.com

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 798
  • Cut Costs & Boost Profits with the First Major Upgrade in 30 YEARS Replacing Rotary Lasers and Historic Clear Tube Altimeter Bubbles
  • Slotozilla's Q3 2025: SBC Lisbon Outcomes and Partnership Expansion
  • Gramercy Tech Launches StoryStream
  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
  • Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
  • Own 327 Acres of American Prime Real Estate with 2 Miles Waterfront Worth In Millions for Just $7 — Worldwide Raffle Launched
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
  • Sons of Liberty Museum Unveils "America at 250" Mobile Exhibit on Veterans Day 2025
  • The Kryder Law Group, LLC Report Reveals Commercial Air Travel Is Safer Than You Think

Similar on ncarol.com

  • New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
  • Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
  • Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
  • Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
  • Holiday Decorations Most Likely to Cause Injuries
  • BoxingRx Announces Full Gym Renovation Ahead of New Ownership's One-Year Anniversary
  • Greensboro's Leading Custom Sign Company Expands Services to Help Local Businesses Strengthen Their Brand Presence
  • Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI
  • More People Than Ever Want a Political Therapist: The Liberatory Wellness Network Is Building a New Standard of Care
  • Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute